文献速递临床免疫临床生化

高维生素B12血症诊断中的挑战:免疫复合物干扰

Challenges in the diagnosis of hypervitaminemia B12. Interference by immunocomplexes.
PubMed 文献 · Clin Chim Acta · 2023-02-18

本研究为为期12个月的前瞻性病例对照观察性研究,旨在提出在Alinity平台上筛查维生素B12免疫测定中抗体介导干扰的算法。结果发现高达45%的病例存在B12免疫复合物干扰,且所有干扰病例的沉淀率均>50%,最低干扰性维生素B12结果为661 pmol/L。结论认为抗体介导的干扰(主要为B12免疫复合物)是相对常见的现象,简单的筛查算法有助于排除健康个体且具有高成本效益。

要点

  • 持续高维生素B12(>554 pmol/L)且无补充或其他原因者应警惕免疫复合物干扰。
  • 在Alinity平台上,高达45%的病例存在B12免疫复合物干扰。
  • 简单的筛查算法可有效排除健康个体,且具有高成本效益。

核心结论

  • 抗体介导的干扰(主要为B12免疫复合物)是相对常见的现象。
  • 简单的筛查算法有助于排除健康个体,且具有高成本效益。

研究设计与样本

  • 观察性、前瞻性、病例对照研究,为期12个月。
  • 病例为持续高钴胺素浓度(>554 pmol/L)且无补充或其他明确原因者;对照为接受维生素B12治疗或酗酒者。
  • 对血清样本进行PEG沉淀、类风湿因子、异嗜性抗体和凝胶渗透色谱(GPC)等大分子干扰研究,并测定各GPC收集组分的白蛋白、总B12、IgG和IgM以绘制色谱图。

主要发现

  • 高达45%的病例存在B12免疫复合物干扰。
  • 所有干扰病例的沉淀率均>50%。
  • 干扰性维生素B12结果最低的个体为661 pmol/L。

关键数值与推荐

  • 高钴胺素血症定义为持续>554 pmol/L且无补充或其他明确原因。
  • 干扰判定依据包括PEG沉淀、类风湿因子、异嗜性抗体和GPC分析。

临床怎么用

  • 对无明确原因的高维生素B12血症患者,应考虑抗体介导的免疫测定干扰。
  • 可采用简单的筛查算法(如PEG沉淀等)排除健康个体,避免不必要的检查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND-AIM: High vitamin B12 concentrations are considered a common finding in clinical practice. Thanks to immunoassay accessibility, vitamin B12 has become a usual test in routine health checkups. However, these analytical methods usually present antibody-mediated interferences. Our aim was to propose an algorithm for the screening of antibody-mediated analytical interferences on vitamin B12 immunoassays on the Alinity platform. METHODS: Observational, prospective, case-control study was performed during 12 months. Individuals with persistently elevated cobalamin concentrations [>554 pmol/L] were considered as cases in the absence of supplementation or other justifying cause. Individuals under treatment with vitamin B12, or in the context of alcoholism were included as controls. A thorough interference study by macromolecules in immunoassays was performed in serum samples: PEG precipitation, rheumatoid factor, heterophile antibodies and gel permeation chromatography (GPC). Albumin, total B12, IgG and IgM were measured in every GPC collected fraction and chromatograms were drafted. RESULTS: Up to 45% of cases presented interference by B12-immunocomplexes and the precipitation for all of them was >50%. The individual with the lowest interfered vitamin B12 result was 661 pmol/L. CONCLUSION: The presence of antibody-mediated interferences, mainly B12-immunocomplexes, is a relatively common phenomenon. A simple algorithm for the screening of interferences is useful and reliable in ruling out healthy individuals and highly cost-effective.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Delgado JA, Pastor García MI, Jiménez NM, et al. Challenges in the diagnosis of hypervitaminemia B12. Interference by immunocomplexes. Clin Chim Acta. 2023. PMID: 36805891. doi:10.1016/j.cca.2023.117267

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。